Thirona Retina BV acquired by Revenio Group subsidiary iCare
Med-Tech Innovation August 21, 2024
Thirona will continue to focus on pulmonary diseases and expanding within the interventional pulmonology space, while its RetCAD division will join forces with a global leader in eye care solutions.
Thirona, a global company specialised in advanced analysis of medical lung images with artificial intelligence (AI), has announced the divestment of Thirona Retina BV to Revenio Group Corporation’s subsidiary Icare Finland Oy.
After demonstrating impressive growth and ‘tremendous’ market potential according to the parent company, the Retina division of Thirona was spun off into Thirona Retina in 2023 to focus entirely on the eye disease market.
By joining forces with iCare, Thirona Retina says it is poised to enhance patient outcomes and drive innovation in eye care. Leveraging iCare’s...